Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is the list for Monday, 2 March, as follows;
Bed Bath & Beyond Inc. (NASDAQ:BBBY) reiterated as Outperform with an $18 target price at Wedbush Securities, with the firm saying its restructuring plan with another 10% of staff cuts is an important step forward in its turnaround.
Continental Resources Inc. (NYSE:CLR) was maintained as Buy but the target price was lowered to 35 from 41 at MKM Partners.
Crown Castle International Corp. (NYSE:CCI): Wells Fargo reiterated its Overweight rating and raised its target price to 165 from 156.
Denali Therapeutics Inc. (NASDAQ:DNLI) was raised to Outperform from Neutral with a 24 target price at Wedbush.
Harpoon Therapeutics Inc. (NASDAQ:HARP) was started as Buy with a 31 target price at SunTrust, effectively giving it more than 100% implied Northside despite the market sell-off.
Trade Desk Inc. (NASDAQ:TTD) was reiterated as Buy with a 305 target price at SunTrust. Wells Fargo raised it to Overweight from Equal Weight with a 310 target price
Uber Technologies Inc. (NYSE:UBER) KeyBanc Capital Markets started Uber as Overweight with a 48 target price.
Have a terrific week